Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Sglt2 Glucose'

Sglt2 Glucose published presentations and documents on DocSlides.

Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
by tatyana-admore
Expert Panelists. Program Goals. Evaluating CV Ri...
JARDIANCE:
JARDIANCE:
by sherrill-nordquist
Newly Approved Drug to Lower HbA1C in Type-2 diab...
FDA warns that SGLT2 inhibitors for diabetes may result in a serious c
FDA warns that SGLT2 inhibitors for diabetes may result in a serious c
by debby-jeon
DKA, a subset of ketoacidosis or ketosis in diabet...
Updates on CVOT Data and Clinical Comparisons That Matter
Updates on CVOT Data and Clinical Comparisons That Matter
by pamella-moone
This program will include a discussion of off-lab...
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
by giovanna-bartolotta
Program Goals. Complementary Mechanism of Action ...
Updates Abound Introduction
Updates Abound Introduction
by sherrill-nordquist
GLP-1 RAs in Combination With Basal Insulin Appro...
Development Committee CHAIR
Development Committee CHAIR
by kittie-lecroy
Lawrence A. Leiter, Endocrinology & Metaboli...
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors
by yoshiko-marsland
Type 1 Diabetes: Expanding Options for Adjunctive...
Diabetes and Hypertension Accelerate Glomerular Hypertension
Diabetes and Hypertension Accelerate Glomerular Hypertension
by aaron
Circulation 2014;129:587-597. Teaching Tool: Hype...
Journal Club 埼玉医科大学　総合医療センター　内分泌・糖尿病内科
Journal Club 埼玉医科大学　総合医療センター　内分泌・糖尿病内科
by jideborn
Department of Endocrinology and Diabetes, . Saitam...
Oral hypoglycemics Jennifer R Marks, MD
Oral hypoglycemics Jennifer R Marks, MD
by finley
Oral hypoglycemics. Factors to consider:. Cost. Av...
Shifting Paradigms in the Selection of
Shifting Paradigms in the Selection of
by alyssa
Antidiabetes. Medications:. Cardiovascular Benefi...
Highlights from ACC 2021
Highlights from ACC 2021
by maisie
Virtua – May 15-17, 2021. ACC 2021 Highlights . ...
The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
by ishaan
John McMurray. BHF Cardiovascular Research Centre,...